Restaurants have spent two years watching the same thing happen at their tables. Plates come back with food still on them. Parties order fewer courses. The check comes out smaller. Enough American kitchens have now noticed the pattern that they are doing something about it, and what they are doing is making the portions smaller on purpose.
The number behind it is the reason. About one in eight American adults currently takes a GLP-1 medicine such as Wegovy or Mounjaro, and 11 percent of adults are taking one specifically for weight loss, up from 3 percent in 2024. That is a large enough share of a dining room that a restaurant cannot plan a menu around the old assumptions any more.
What changes at the table is not just how much. Most people taking a GLP-1 report ordering differently once they start: smaller portions, more protein, more vegetables. A kitchen that only shrinks the plate and changes nothing else is answering half the question, which is why some of the menu changes showing up now are new smaller dishes rather than the same dish with less on it.
The part that surprises people is that this is not a story about GLP-1 users staying home. Eighty-seven percent of them say they still enjoy going out to eat and count restaurants as part of their life. They are still at the table. They are ordering a different meal than they used to, and the restaurants that have worked that out are the ones adjusting the menu instead of waiting to see what happens.
It is worth saying what this does not settle. A smaller portion at a lower price is good news if it arrives as a real option, and less good if it arrives as the same price for less food. Which of those it turns out to be is going to vary restaurant by restaurant, and it is early enough that nobody can tell you yet how that lands across the country.
If you take a GLP-1 and you have been quietly ordering an appetizer as your main course, you are not doing anything unusual. You are part of a group big enough that kitchens are now building menus around it.
Key details
One in eight American adults currently takes a GLP-1 drug such as Wegovy or Mounjaro.
Eleven percent of US adults take a GLP-1 for weight loss, up from 3 percent in 2024.
Most GLP-1 users have changed how they order at restaurants, generally choosing smaller portions, more protein and more vegetables.
Eighty-seven percent of GLP-1 users say they still enjoy eating out and consider restaurants part of their lifestyle.
Some American restaurants are responding by reducing portion sizes and adding smaller dishes to the menu.
Sources
Irish Dentist: The GLP-1 effect comes to the dinner table: Why American restaurants are reducing portions
Originally published on GLP-1 Nation.
Every Sunday, the weekly newsletter pulls the full week together: the news from GLP-1 Nation, the access updates from GLP1Laws, the latest GLP-1 Studio podcast episodes, and what changed in the Cozy Butter community.